Fred Alger Management’s Viridian Therapeutics VRDN Stock Holding History

Fred Alger Management’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.07M	Buy
2023 Q3	–	Sell
2023 Q2	$2.55M	Sell
2023 Q1	$8.23M	Sell
2022 Q4	$12.5M	Buy
2022 Q3	$5.36M	Buy